Global Wound Debridement Market 2018-2025 - The Rise in the Incidence of Wound Infections is Augmenting Growth

DUBLIN, Nov. 16, 2018 /PRNewswire/ --

The "Wound Debridement Market Analysis Report By Product (Gels, Ointments & Creams), By Method, By Wound Type (Diabetic Foot, Pressure Ulcers), By End Use, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global wound debridement market size is anticipated to reach USD 6.97 billion by 2025 at a 6.10% CAGR during the forecast period. Rising cases of injuries that require cleaning and removal of necrotic tissue are leading to increasing demand for wound debridement products.

Increasing incidence of diabetes and obesity escalates the level of chronic wounds such as diabetic foot ulcers. As per the International Diabetes Federation, the incidence of diabetes is expected to reach 642 million by 2040. Prevention of wound infection is one of the major concerns for diabetic patients, making wound debridement vital.

With increase in number of diabetics in US, demand for wound debridement is on a rise. Burns are the most common wounds and account for around 195,000 deaths annually. This, in addition to rise in awareness regarding the importance of wound debridement, is expected to positively affect the market in the coming years.

Development of advanced wound debridement products is also boosting market growth. For instance, launch of keratin-based wound care products that are used along with dressings have proven to be extremely helpful in wound re-epithelialization. The keratin matrix is absorbed in the wound and eliminates the need for dressing change. Such developments are anticipated to create growth opportunities for market players in the coming years.

Further key findings from the study suggest:

• Gels accounted for the largest share by product in 2017 due to advantages such as no inflammation, reduced bleeding, and safe removal of necrotic tissues without causing infection
• By wound type, diabetic foot ulcers are estimated to form the fastest growing segment due to high prevalence of diabetes. About 15% of diabetic foot ulcers result in amputation. Therefore, need to heal the wound in its nascent stage is necessary
• Asia Pacific is anticipated to witness lucrative growth over the forecast period. Progressive economy, reforms to improve infrastructure, high unmet needs of a massive population, and availability of skilled labor is expected to drive the market in this region
• Major players in this market include Acelity L.P. Inc.; Smith & Nephew; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group; Paul Hartmann; Mlnlycke Health Care; Lohmann & Rauscher; Medline Industries; and Integra Lifesciences

Key Topics Covered

Chapter 1 Research Methodology
1.1 Information procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing incidence of pressure ulcers, diabetic foot and surgical procedures
3.1.1.2 Increasing number of drug launches
3.1.1.3 Rise in the incidence of wound infections
3.1.2 Market Restraint Analysis
3.1.2.1 High cost of advanced debridement devices/therapy
3.1.2.2 Advanced effects on skin due to dressings
3.2 Penetration & growth prospect mapping
3.3 Wound Debridement market- SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter's

Chapter 4 Product Estimates & Trend Analysis
4.1 Wound debridement market: Product movement analysis
4.2 Gels
4.3 Ointment and creams
4.4 Surgical devices
4.5 Medical gauze & pads
4.6 Ultrasonic devices
4.7 Others

Chapter 5 Method Estimates & Trend Analysis
5.1 Wound Debridement market: Method movement analysis
5.2 Autolytic debridement
5.3 Enzymatic debridement
5.4 Surgical debridement.
5.5 Mechanical debridement.
5.6 Others

Chapter 6 End-use Estimates & Trend Analysis
6.1 Wound debridement market: End-use movement analysis
6.2 Hospitals
6.3 Homecare
6.4 Others

Chapter 7 Wound type Estimates & Trend Analysis
7.1 Wound debridement market: Wound type movement analysis
7.2 Diabetic Foot Ulcer.
7.3 Pressure Ulcer
7.4 Venous Leg Ulcer
7.5 Burn wounds
7.6 Others

Chapter 8 Regional Estimates & Trend Analysis
8.1 Wound Debridement market share by region, 2017 & 2025
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 Latin America
8.6 MEA

Chapter 9 Competitive Landscape
9.1 Strategy framework
9.2 Company Profiles

• Coloplast
• ConvaTec
• Medline Industries, Inc.
• Smith & Nephew
• Mlnlycke Health Care AB.
• B. Braun Melsungen AG
• Paul Hartmann AG
• Acelity L.P., Inc.
• Lohmann & Rauscher International Gmbh & Co KG
• Integra Lifesciences

For more information about this report visit https://www.researchandmarkets.com/research/t2jnl7/global_wound?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets